Bardy GH, Lee KL, Mark DB, Poole JE, Fishbein DP, Singh SN, Troutman CL, Christian VL, Anderson J, Clapp-Channing NE, Johnson GW, for the SCD-HeFT Investigators. SCD-HeFT: Prevention of Sudden Cardiac Death in Patients with Congestive Heart Failure Trial. The ABC Digest of Urban Cardiology. 6:18-22;1999.
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman CL, Anderson J, Johnson GW, McNulty SE, Clapp-Channing N, Davidson-Ray L, Fraulo ES, Fishbein DP, Luceri RM, Ip JH for the SCD-HeFT Investigators. Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. N Engl J Med 352:225-237; 2005.
Bardy GH, Lee KL, Mark DB for the SCD-HeFT Investigators. Correspondence regarding Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. N Engl J Med 352:2023-2024; 2005.
Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Lee KL, and Bardy GH for the SCD-HeFT Investigators. Cost effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 114:135-142; 2006.
Friedman E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb and the SCD-HeFT Investigators. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J 152:940.e1-8;2006.
Singh SN, Poole JE, Anderson J, Hellkamp AS, Karasik P, Mark DB, Lee KL and Bardy GH for the SCD-HeFT Investigators: Role of amiodarone or implantable cardioverter/ defibrillator in patients with atrial fibrillation and heart failure. Am Heart J 2006;152:974.e7-11.
Anderson J, Bardy GH. Key Clinical Insights From the Sudden Cardiac Death in Heart Failure Trial. Journal of CV Nursing 2006;21(6):463-468.
Dickinson MG, Ip JH, Olshansky B, Hellkamp AS, Anderson J, Poole JE, Mark DB, Lee KL, Bardy GH, for the SCD-HeFT Investigators. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: Mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 153:573-578;2007.
Mindel JS, Anderson J, Johnson G, Hellkamp A, Poole JE, Mark DB, Lee KL, and Bardy GH for the SCD-HeFT Investigators. Absence of Bilateral Vision Loss from Amiodarone: A Randomized Trial. Am Heart J 2007;153:837-842.
Freudenberger RS, Hellkamp AS, Halperin JL, Poole JE, Anderson J, Johnson GW, Mark DB, Lee KL, and Bardy GH for the SCD-HeFT Investigators. The Risk of Thromboembolism in Heart Failure, An Analysis from the Sudden Cardiac Death in Heart Failure Trial. Circulation 2007;115:2637-2641
Olshansky, B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, Domanski MJ, Mark DM, Lee KL, and Bardy GH for the SCD-HeFT Investigators. Where patients with mild to moderate heart failure die: Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal, Volume 153(), 2007: 1089-94
Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol 2008;19(7):720-724.
Olshansky, B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, Domanski MJ, Mark DM, Lee KL, and Bardy GH for the SCD-HeFT Investigators. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. JACC 2008;51(13):1277-1282.
Mitchell JE, Hellkamp AS, Mark DB, Poole JE, Anderson J, Poole JE, Lee KL, Bardy GH for the SCD HeFT Investigators. Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J. 2008;155(3):501-506.
Gula LJ, Klein GJ, Hellkamp AS, Massel D, Krahn AD, Skanes AC, Yee R, Anderson J, Johnson GW, Poole JE, Mark DB, Lee KL, Bardy GH. Ejection fraction assessment and survival: An analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2008;156:1196-1200.
Al-Khatib SM, Hellkamp AS, Lee KL, Anderson J, Poole JE, Mark DB and Bardy GH. Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). J Cardiovasc Electrophysiol. 2008;10;1059-65.
Poole JE, Johnson GW, Hellkamp As, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic Importance of Defibrillator Shocks in Heart Failure. N Engl J Med 2008;359;1009-1017.
Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, Lee KL, Bardy GH for the SCD-HeFT Investigators. Quality of Life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008;359(10);999-1008.
Chapa DW, Lee HJ, Kao CW, Friedmann E, Thomas SA, Anderson J, Bardy GH. Reducing Mortality with Device Therapy in Heart Failure Patients without Ventricular Arrhythmias. American Journal of Critical Care 2008;17:443-453.
Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Anderson J, Chung K, Wong WS, Mark DB, Lee KL, and Bardy GH for the SCD-HeFT Investigators. No Benefit From DFT Testing in the Sudden Cardiac Death in Heart Failure Trial. J Am Coll Cardiol. 2008;52(7):551-556.
Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 2008;118(20):2022-8.
Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson, J, Mark DB, and Bardy GH. Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population. Circulation 2009;120:835-842.
Packer DL, Prutlin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, and Bardy GH. Impact of ICD, Amiodarone and Placebo on the Mode of Death in Stable Patients with Heart Failure: Analysis from SCD-HeFT. Circulation 2009 in press
Bardy GH, Lee KL, Mark DB, Poole JE, Toff WD, Tonkin AM, Smith W, Dorian P, Packer DL, White RD, Longstreth WT Jr, Anderson J, Johnson G, Bischoff E, Yallop JJ, McNulty S, Ray LD, Clapp-Channing NE, Rosenberg Y, Schron EB for the HAT Investigators. Home Use of Automated External Defibrillators for Sudden Cardiac Arrest. N Engl J Med 2008;358(17);1793-1804.
Bardy GH, Lee KL, Mark DB, Poole JE, Toff WD, Tonkin AM, Smith W, Dorian P, Yallop JJ, Packer DL, White RD, Longstreth W, Anderson J, Johnson G, Bischoff E, Munkers CD, McNulty S, Davidson-Ray L, Clapp-Channing NE, Rosenberg Y, Salive M, Schron EB for the HAT Investigators. Rationale and Design of the Home Automatic External Defibrillator Trial (HAT). Am Heart J. 2008;155(3):455-454.
Walsh MN, Lee KL, and Bardy GH for the SCD-HeFT Investigators. Correlation of Six Minute Walk Test and NYHA Classification For Patients Enrolled in the Sudden Cardiac Death in Heart Failure (SCD-HeFT) Trial. HFSA meeting in Washington, DC, September 11, 2001.
Schreuder AB, Reinhall PG, Poole JE, and Bardy GH for the SCD-HeFT Investigators. Value of Nonlinear Dynamic Measures in SCD-HeFT Patients with and without ventricular fibrillation. PACE 24:694A, 2001.
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Troutman CL, Anderson J, Johnson GW, McNulty SE, Davidson-Ray L, Clapp-Channing N, Luceri RM, Ip J for the SCD-HeFT Investigators. The Sudden Cardiac Death in Heart Failure Trial. American College of Cardiology Annual Meeting. Latebreaking Clinical Trials Abstract, March 8, 2004.
Poole JE, Johnson GW, Callans DJ, Raitt MH, Yee R, Reddy RK, Wilber DJ, Guarnieri T, Talajic M, Marchlinski FE, Lee KL and Bardy GH for the SCD-HeFT Investigators. Analysis of Implantable Defibrillator Shock Electrograms in The Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm Society Meetings, San Francisco, CA, May 20, 2004, Heart Rhythm, Volume 1, p. S178, 2004.
Poole JE, Anderson J, Johnson GW, Troutman CL, McNulty SE, Lee KL and Bardy GH for the SCD-HeFT Investigators. Baseline ECG Data and Outcome in The Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm Society Meetings, San Francisco, CA, May 22, 2004, Late Breaking Clinical Trials Session.
Daniel B. Mark, Charlotte L. Nelson, Kevin J. Anstrom, Sana M. Al-Khatib, Anastasios A. Tsiatis, Jeanne Poole, George Johnson, Jill Anderson, Patricia A. Cowper, Nancy E. Clapp-Channing, Linda Davidson-Ray, Kerry L. Lee, Gust H. Bardy for the SCD-HeFT Investigators. Cost-Effectiveness of ICD Therapy in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Association, New Orleans, November 10, 2004.
Daniel P. Fishbein, Mary N. Walsh, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy for the SCD-HeFT Investigators. Baseline six-minute walk distance in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Association, New Orleans, November 10, 2004.
Poole JE, Johnson GW, Callans DJ, Raitt MH, Yee R, Reddy RK, Wilber DJ, Guarnieri T, Talajic M, Marchlinski FE, Anderson J, Lee KL, and Bardy GH for the SCD-HeFT Investigators: Rhythm precursors in those treated for ventricular tachycardia or ventricular fibrillation in SCD-HEFT. Heart Rhythm Vol 2: No 5 Heart Rhythm Society Meetings, New Orleans, May 5, 2005.
Olshansky B, Lee KL, Poole JE, Anderson J, Johnson GW, Wood F, Boineau R, Domanski MJ, McNulty SE, Mark DB, Packer DL, Bardy GH: Do ICDs alter the location of death in heart failure patients? Heart Rhythm Vol 2: No 5. Heart Rhythm Society Meetings, New Orleans, May 5, 2005.
Bardy GH, Lee KL, Boehmer JP, Mark DB, Poole JE, Fisbein DP, Hellkamp AS, McNulty SE, Anderson J, Johnson GW, Boineau R, Domanski MJ: The progression of congestive heart failure over the course of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm Vol 2: No 5. Heart Rhythm Society Meetings, New Orleans, May 5, 2005.
Packer DL, Bernstein, R, Wood F, Boehmer JP, Carlson MD, Frantz RP, Mitchell LB, McNulty SE, Poole JE, Rogers J, Anderson J, Walsh MN, Lee KL, Bardy GH, Boineau R, Domanski MJ: Impact of Amiodarone versus implantable cardioverter defibrillator therapy on the mode of death in congestive heart failure patients in the SCD-HeFT trial. Heart Rhythm Vol 2: No 5. Heart Rhythm Society Meetings, New Orleans, May 5, 2005.
Ip JH, Dickinson MG, Olshansky B, Hellkamp A, Anderson A, Poole JE, Mark DB, Lee KL, Bardy GH. Does Statin Therapy Decrease Mortality in Patients with Cardiomyopathy? Unanticipated Observations from SCD-HeFT. Dallas, American Heart Association 2005. Circulation Vol 112, p.II-382, 2005.
Singh SN, Poole JE, Anderson J, Hellkamp AS, Lee KL, and Bardy GH for the SCD-HeFT Investigators. Interaction of Atrial Fibrillation with Amiodarone or ICD in Patients with Heart Failure. A SCD-HeFT Substudy. Dallas, American Heart Association 2005. Circulation Vol 112, p.II-675, 2005.
Russo AM, Poole JE, Anderson J, Hellkamp AS, Boineau R, Domanski M, Mark DB, Lee KL, Bardy GH for the SCD-HeFT Investigators. The Sudden Cardiac Death in Heart Failure Trial: Are There Differences Between Men and Woman? Dallas, American Heart Association 2005. Sudden Cardiac Death in Heart Failure Trial. Dallas, American Heart Association 2005. Circulation Vol 112, p.II-530, 2005.
Olshansky B, Poole JE, Johnson G, Anderson J, Hellkamp AS, Mark DB, Lee KL, Bardy GH for the SCD-HeFT Investigators. Syncope Predicts the Outcome of Cardiomyopathy Patients - Analysis of the SCD-HeFT Trial. Dallas, American Heart Association 2005. Sudden Cardiac Death in Heart Failure Trial. Dallas, American Heart Association 2005. Circulation Vol 112, p.II-454, 2005.
Sharma A, Poole JE, Anderson J, Hellkamp A, Mark DB, Lee KLL, and Bardy GH, for the SCD-HeFT Investigators. Mortality in Non-Ischemic Dilated Cardiomyopathy with LVEF > 35% during Follow Up in the Sudden Cardiac Death in Heart Failure Trial. Dallas, American Heart Association 2005. Circulation Vol 112, p.II-530, 2005.
Mitchell JE, Battle J, Poole JE, Anderson J, Hellkamp AS, Mark DB, Lee KL, Bardy GH for the SCD-HeFT Investigators. Observations Regarding Outcome In Minorities in the Sudden Cardiac Death in Heart Failure Trial. Dallas, American Heart Association 2005. Circulation Vol 112, p.II-675, 2005.
Dickinson MG, Anderson J, Hellkamp AS, Poole JE, Johnson GW, Mark DB, Lee KL, Bardy GH, Freudenberger RS, for the SCD-HeFT Investigators. Decreased Impact of Implantable Defibrillators on Sudden Cardiac Death in Patients with Renal Insufficiency and Heart Failure: An Analysis of the SCD-HeFT. Heart Rhythm Society 2006, Abstract AB19.
Dickinson MG, Anderson J, Hellkamp AS, Johnson GW, Poole JE, Mark DB, Lee KL, Bardy GH, for the SCD-HeFT Investigators. Spironolactone Was Safe But Did Not Reduce Mortality or the Need for an ICD In Chronic Moderate Heart Failure: Observations from the Sudden Cardiac Death Heart Failure Trial. Heart Rhythm Society 2006, Abstract AB19-3.
Dickinson MG, Anderson J, Hellkamp AS, Johnson GW, Poole JE, Mark DB, Lee KL, Bardy GH, Singh SN, for the SCD-HeFT Investigators. Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HeFT. Heart Rhythm Society 2006, Abstract AB24-2.
Poole JE, Johnson G, Hellkamp A, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Wilber DJ, Talajic M, Mark DB, Lee KLL, and Bardy GH, for the SCD-HeFT Investigators. Mortality after Appropriate and Inappropriate shocks in SCD-HeFT. Nice, France, Cardiostim 2006. Europace Vol 8, p.104/1, June 2006.
Exner DV, Mitchell LB, Anderson J, Poole J, Bardy GH, Hellkamp A, Mark DB, Lee KLL for the SCD-HeFT Investigators. Association of diabetes with clinical outcomes and defibrillator efficacy in SCD-HeFT. Nice, France, Cardiostim 2006. Europace Vol 8, p.104/4, June 2006.
Gold MR, McNulty S, Anderson J, Mark DB, Lee KL, and Bardy GH for the SCD-HeFT Investigators. T-Wave Alternans SCD-HeFT Study: Primary Endpoint Analysis. American Heart Association 2006 Scientific Sessions, November 12-15, 2006, Chicago, IL.
Mitchell JE, Hellkamp AS, Anderson J, Johns GW, Poole JE, Mark DB, Lee KL, and Bardy GH for the SCD-HeFT Investigators. Thyroid Function and Mortality in the Sudden Death in Heart Failure Trial. American Heart Association 2006 Scientific Sessions, November 12-15, 2006, Chicago, IL.
Dickinson MG, Ip JH, Hellkamp AS, Anderson, J, Johnson GW, Singh SN, Poole JE, Mark DB, Lee KL, Bardy GH, for the SCD-HeFT Investigators. Beta Blocker (BB) Use Was Assosciated with Reduced Atrial Fibrillation (AF) and Flutter (AFL) in the sudden Cardiac Death Heart Failure Trial (SCD-HeFT). American Heart Association 2006 Scientific Sessions, November 12-15, 2006, Chicago, IL. Poster, Abstract 1872/C130.
Al-Khatib SM, Hellkamp AS, Lee KL, Mark DB, Bardy GH, the SCD-HeFT Investigators. Implantable Cardioverter Defibrillator Therapy Improves the Survival of Patients With Prior Coronary Revascularization: Data From the SCD-HeFT Trial. Am Coll of Cardiol Scientific Sessions, New Orleans, LA Sunday, March 25, 2007. J Am Coll Cardiol 49:12A;2007.
Sandesara CM, Olshansky B, Anderson J, Hellkamp AS, Johnson G, Poole JE, Mark DB, Lee KL and Bardy GH for the SCD-HeFT Investigators. Is There a Relationship Between Weight and Mortality Risk in Optimally Managed Heart Failure Patients?: Observations from SCD-HeFT. Am Coll of Cardiol Scientific Sessions, New Orleans, LA Sunday, March 25, 2007. J Am Coll Cardiol 49:49A;2007.
Stevenson LW, O'Connor CM, Sopko G, Hellkamp AS, Lee K, Packer DL, Mark DB, Bardy GH, SCD-HeFT Investigators. No Delay in Sudden Death but Contribution Diminishes in Advanced Heart Failure: Comparison From SCD-HeFT to ESCAPE Am Coll of Cardiol Scientific Sessions, New Orleans, LA. Monday, March 26, 2007. J Am Coll Cardiol 49:71A;2007.
Blatt JA, Poole JE, Anderson J, Johnson G, Mark DB, Lee KL, and Bardy GH for the SCD-HeFT Investigators. No Benefit from DFT Testing in the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm Society Meetings, Denver, CO. May 11, 2007. Heart Rhythm Volume 4: Page, S81-AB37-5; 2007.
Jay Chen, MD, Jeanne E. Poole, MD, George Johnson, BSEE, Jill Anderson, RN, Freda Wood, RN, Anne S. Hellkamp, MS, Douglas L. Packer, MD, Daniel B. Mark, MD, Kerry L. Lee, PhD, Gust H. Bardy, MD. Sudden Tachyarrhythmic Death Despite an Implantable Cardioverter Defibrillator: Data from the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm Society Meeting 2009 Abstract Presentation. AB14-6 Publication pending
Jordan M. Prutkin, MD, Jeanne E. Poole, MD, George Johnson, BSc, Jill Anderson, RN, Daniel B. Mark, MD, Kerry L. Lee, MD and Gust H. Bardy, MD. Post-Shock Pacing During DFT Testing Does Not Predict Need For Post-Shock Pacing Following Appropriate ICD Shocks in SCD-HeFT. Heart Rhythm Society Meeting 2009 Abstract Poster Presentation. PO06-135 Publication pending
Pierre S. Aoukar, MD, Jeanne E. Poole, MD, George W. Johnson, BS, Jill Anderson, RN, Daniel B. Mark, MD, MPH, Kerry L. Lee, PhD and Gust H. Bardy, MD. The Short Long Short Trigger of Ventricular Arrhythmias: Analysis of the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm Society Meeting 2009 Abstract Poster Presentation. PO01-73 Publication pending
Prutkin JM, Poole JE, Johnson G, Anderson J, Mark DB, Lee KL, and Bardy GH: Infrequent Need for Pacing Following Implantable Cardioverter-Defibrillator Shocks: Analysis of the Sudden Cardiac Death in Heart Failure Trial. Circulation, Oct 2008; 118: S_674.
Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozffarian D, Linker DT, Maggioni A, Anand I, Fishbein DP, Johnson GW, Anderson, J, Mark DB, Bardy GH for the SCD-HeFT Investigators. Use of Seattle Heart Failure Model to Identify Benefit vs Harm From A Primary Prevention ICD. Heart Rhythm Society, San Francisco, CA, USA May 14-17, 2008. Suppl. to Heart Rhythm Vol 5, Issue 5S, page S78, abstract AB37-3.
Gula LJ, Klein GJ, Hellkamp AS, Massel D, Krahn AD, Skanes AC, Yee R, Anderson J, Johnson GW, Poole JE, Mark DB, Lee KL and Bardy GH. Outcomes in SCD-HeFT Were Independent of Imaging Modality Used for EF Assessment. Heart Rhythm Society, San Francisco, CA, USA. May 14-17, 2008. Suppl. to Heart Rhythm Vol 5, Issue 5S, page S195, abstract PO2-97.
Wong WS, Poole JE, Hellkamp AS, Johnson GW, Anderson J, Mark DB, Lee KL and Bardy GH. Mortality Risk Increases for Each Subsequent Ventricular Arrhythmia Treated with an ICD Shock: Results from the Sudden Cardiac Death in Heart Failure Trial. American College of Cardiology meetings, Chicago, Il. J Am Coll Cardiol. 51;A19, 2008.
Strauss DG, Poole JE, Wagner GS, Selvester RH, Miller JM, Anderson J, Johnson G, McNulty SE, Mark DB, Lee KL, Bardy GH, Wu KC. Quantification of Myocardial Scar Using a Simple ECG Tool dentifies Patients at Risk for Sudden Arrhythmic Death: An Analysis of SCD-HeFT. American Heart Association Scientific Sessions, Orlando FL. Abstract Poster 2482. S646 Suppl 2, Circulation Vol 120, No.18, Nov. 3, 2009.
Bardy GH, Lee KL, Mark DB, Poole JE, Toff WD, Tonkin AM, Smith WB, Paul Dorian, Julie J. Yallop, Douglas L. Packer, Roger D. White, Will Longstreth, Jill Anderson, George Johnson, Eric Bischoff, Steven McNulty, Linda Davidson Ray, Nancy E. Clapp-Channing, Yves Rosenberg, and Eleanor B. Schron for the HAT Investigators. Home Use of Automated External Defibrillators for Sudden Cardiac Arrest. Late Breaking Clinical Trials American College of Cardiology meetings, Chicago, Il. 1 April 2008.
Anderson J, Munkers CD, Bischoff E, Johnson GW, Poole JE, Brown A, Lee KL, Bardy GH. AED and CPR Video Training in the Home Automatic External Defibrillator Trial (HAT). World Congress on Cardiac Pacing and Electrophysiology 2007, Poster Session 3 [05]. World Congress of Pacing and Electrophysiology, Rome, Italy, December 5, 2007.Giornale Italiano di Aritmologia e Cardiostimolazione Vol 10, abstract 05, 2007.
Bischoff E, Johnson GW, Anderson J, Munkers CD, Brown A, and Bardy GH.Telecardiology and Electronic Clinical Trial Management Systems in a Web 2.0 World. World Congress of Pacing and Electrophysiology, Rome, Italy, December 5, 2007.Giornale Italiano di Aritmologia e Cardiostimolazione Vol 10, page 113, abstract 46, 2007.
Thomas SA, Friedmann E, Lee HJ, Son H, Morton PG. In the Home Automatic External Defibrillator Trial Psychologically Distressed Patients and Spouses Remain Distressed 2 Years After Receiving Training to Respond to Sudden Cardiac Arrest. American Heart Association Scientific Sessions, Orlando FL. Abstract Poster 2701. S683 Suppl 2, Circulation Vol 120, No. 18, Nov. 3, 2009.